Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The Real Value Of A Breakthrough Therapy Designation:

<< Previous

Bullboard Posts

Next >>

Comment by toade1313on Oct 05, 2024 5:59pm

219 Views

Post# 36254748

RE:RE:RE:The Real Value Of A Breakthrough Therapy Designation:

I have asked both on the Theralase live chat and the info@therslase.com whether shareholders would hear a)when pre-BTD was filed, b) when BTD was filed, or c) when BTD was approved or denied. I have received no answer to either.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec